Kinetics 99mTc-MIBI in breast cancer according to the results of mathematical modeling

Main Article Content

N. A. Nikolov

Abstract

Objective: qualitative description of the kinetics of 99mTc-MIBI in the breast tumor to assess chemoresistance.

Analysis of the kinetics of 99mTc-MIBI in breast tumors is according to mathematical modeling. The mathematical model shows that the main parameters mammostsintigrafy with 99mTc-MIBI to be considered for evaluation of tumor chemoresistance are effective tumor blood flow, rate of excretion radiopharmaceutical with cells, clearance of blood from the radiopharmaceutical, the level of radiopharmaceutical washout from the tumor.

Bibl. 13, figures 5.

Article Details

How to Cite
Nikolov, N. A. (2013). Kinetics 99mTc-MIBI in breast cancer according to the results of mathematical modeling. Electronics and Communications, 18(1), 38–44. https://doi.org/10.20535/2312-1807.2013.18.1.187027
Section
Biomedical devices and systems

References

Cordobes M.D., Starzec A., Delmon-Moingeon L. et al. (1996), [Technetium-99m-Sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression]. Vol. 37, no. 2, pp. 286 – 289.

Linn S. C., Giaccone G., van Diest P. J. et al. (1995), [Prognostic relevance of P-glycoprotein expression in breast cancer]. Annals of Oncology. No. 6. pp. 679-685.

Liu Z., Stevenson G.D., Barrett H.H. et al. (2005), [Imaging recognition of inhibition of multidrug resistance in human breast cancer xenografts using 99mTc-labeled sestamibi and tetrofosmin]. Nucl. Med. Biol. Vol. 32, No. 6. pp. 573 – 583.

Maini C.L., Tofani A., Sciuto R. et al. (1997), [Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma]. J. Nucl. Med. Vol. 38, No. 10. pp. 1546-1551.

Mubashar M., Harrington K.J., Chaudhary K.S. et al. (2002), [99mTc-Sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer]. J. Nucl. Med. Vol. 43. pp. 519 – 525.

Piwnica-Worms D., Chiu M.L., Budding M. et al. (1993), [Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex]. Cancer Res. Vol. 53.pp. 977 – 984.

Salmon S.E., Grogan T.M., Miller T. et al. (1989), [Prediction of doxorubicin resistance in vitro in myeloma, lymphoma and breast cancer by P-Glycoprotein staining]. J. of the National cancer institute. Vol. 81, no. 9. pp. 696 – 701.

Sciuto R., Pasqualoni R., Bergomi S. et al. (2002), [Prognostic value of 99mTc-Sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy]. J. Nucl. Med. Vol. 43, No. 6. pp. 745 – 751.

Vecchio S.D., Ciarmiello A., Pace L. et al.(1997), [Fractional retention of technetium-99m-Sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients]. J. Nucl. Med. Vol. 38, No. 9 , pp. 1348 – 1351.

Kamіnska A.L., Nіkolov M.O., Makarenko A.V., Muravka V.O. (2010), [Peculiarities of assessment of Kidney blood flow by indirect renangiography findings]. Ukrainian Journal of Radiology.Vol. XVIII, No. 3. pp. 291-294. (Ukr.)

Moiseenko V.M. (2002),["Natural History" growth of breast cancer]. Practical oncology. Vol. 3, No. 1. –pp. 6 – 14.(Rus.)

Romanovsky Yu.M., Stepanova N.V., Chernavsky D.S. (1984), [Mathematic biophysics]. Moskow.: Nauka, P. 304. (Rus.)

Usov V.Yu. (2004), [Scintigraphic diagnosis of malignant tumors of the breast]. Proceedings of the All-Russia Scientific Forum "Achievements and prospects of modern radiation diagnosis," Moscow, International Trade Centre, pp. 389-393. (Rus.)